Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Multimorbidity and health-related quality of life after tuberculosis treatment in Zimbabwe: A cross-sectional study with household comparators.
CALDERWOOD, CJ; Marambire, ET; Musunzuru, T; Madziva, K; Kavenga, F; Muringi, E; Dixon, J; Mutsvangwa, J; Gregson, CL; FERRAND, RA; FIELDING, K; KRANZER, K;
2026
PLOS global public health, (2026).6 9 10.1371/journal.pgph.0007119.
Evaluating the acceptability, feasibility, and implementation fidelity of a multipurpose mobile health (mHealth) app used for Tuberculosis (TB) contact tracing by Ward-Based Outreach Teams (WBOTs) in South Africa.
Mudzengi, DL; Tsope, L; Hippner, P; Mboniswa, F; Mpanza, T; Dube, T; Lessells, R; Govender, I; Gumede, D; GRANT, AD; Fielding, K; Chetty-Makkan, CM; Velen, K; Charalambous, S;
2026
PLOS global public health, (2026).6 8 10.1371/journal.pgph.0007120.
Type 2 Diabetes Reshapes the B-Cell Compartment in Tuberculosis, with Reduction of Transitional B Cells and Expansion of Plasmablasts.
Petrone, L; Najafi-Fard, S; Altera, AM G; Aiello, A; Cuzzi, G; Farroni, C; Petruccioli, E; Vanini, V; Salmi, A; Barbarossa, G; Pajno, MC; Scolieri, P; DOCKRELL, HM; Joosten, SA; Mellini, V; Palmieri, F; Gualano, G; Goletti, D; INMI TB-T2D study group(1,**),;
2026
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2026). 10.1016/j.ijid.2026.109083.
Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.
Wattiau, P; Omar, SV; Joseph, L; Demoitié, M-A; Gilbert, M; AYLES, HM; Diacon, AH; Ginsberg, AM; Hatherill, M; Hellström, E; Innes, JC; Malahleha, M; Martinson, N; Muyoyeta, M; Nduba, V; Tait, DR; Wilkinson, RJ; Roman, F;
2026
The Journal of infectious diseases (2026). 10.1093/infdis/jiag428.
Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO <i>Mycobacterium tuberculosis</i> mutation catalog.
Hermans, N; PHELAN, J; Sorrentino, R; Boysen, F; Sherry, NL; Miotto, P; Cirillo, DM; Chindelevitch, L; Rodwell, TC; Barilar, I; Niemann, S; Andres, S; Mischnik, A; Horan, K; Bond, K; Globan, M; Rubinstein, M; Losev, Y; CLARK, TG; Mitarai, S; Iskakova, A; Slyzkyi, A; Köser, CU; Kremer, K; Anthony, R;
2026
Microbiology spectrum (2026). 10.1128/spectrum.01821-26.
Cohort profile: the Entebbe Mother and Baby Study (EMaBS).
WEBB, EL; Walusimbi, B; Komata, R; ELLIOTT, AM; The EMaBS Study Team,;
2026
BMJ open, (2026).16 8 10.1136/bmjopen-2026-118325.
Tuberculosis policy should shift focus to population-level interventions for greatest impact.
Horton, KC; SCHWALB, A; HARKER, MJ; Goscé, L; Venero-Garcia, E; O'Brien, L; Gun, A; Sumner, T; McQuaid, CF; Clark, RA; Prys-Jones, TO; Bakker, R; Liu, YE; Kubjane, M; Lienhardt, C; WHITE, RG; Houben, RM G J;
2026
Nature Health (2026). 10.1038/s44360-026-00197-9.
Comment on: Precision geospatial targeting for cost-effective tuberculosis case finding in Eastern Uganda: A quasi-experimental study.
MCCREESH, N; KHAN, PY;
2026
Therapeutic advances in infectious disease, (2026).13, 10.1177/20499361261477179.
Synthesis, Characterization, and Inhibitory Potential of Fagonia arabica L. Phytochemicals Coated Gold Nanoparticles Against Drug-Resistant Mycobacterium tuberculosis.
Mukhtar, F; Khan, MT; Lodhi, MS; Ahmad, I; Alshaya, DS; Al-Qahtani, AA; Khan, AS; CLARK, TG;
2026
Chemistry & biodiversity, (2026).23 8 10.1002/cbdv.71572.
Tuberculosis comorbidities, multimorbidity and mortality amongst adults in South Africa: A prospective cohort study nested in a trial.
Wood, GK; Byrne, RL; Lebina, L; Worrall, E; Abraham, P; WEBB, EL; MacPherson, P; Martinson, NA; Wingfield, T;
2026
PLOS global public health, (2026).6 8 10.1371/journal.pgph.0006720.